FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

taco uil

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Co-author Network

Publications

TOP 3
J de Vrij; Steve J Cramer; I J C Dautzenberg; Danijela Koppers-Lalic; Leif Lindholm; Maria K Magnusson; taco uil; S K van den Hengel; Jort Vellinga; C S Verissimo; Rob Hoeben
A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction.
taco uil; Jort Vellinga; Jeroen de Vrij; Sanne K van den Hengel; Martijn J W E Rabelink; Steve J Cramer; Julia J M Eekels; Yavuz Ariyurek; Michiel van Galen; Rob Hoeben
Directed adenovirus evolution using engineered mutator viral polymerases.
Jeroen de Vrij; Sanne K van den Hengel; taco uil; Danijela Koppers-Lalic; Iris J C Dautzenberg; Oscar M J A Stassen; Montserrat Bárcena; Masato Yamamoto; Corrina M A de Ridder; Robert Kraaij; Kitty M Kwappenberg; Marco W Schilham; Rob Hoeben
Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of taco uil (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: J de Vrij; Steve J Cramer; I J C Dautzenberg; Danijela Koppers-Lalic; Leif Lindholm; Maria K Magnusson; taco uil; S K van den Hengel; Jort Vellinga; C S Verissimo; Rob Hoeben
A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction.
Gene therapy 2012;19(9):899-906.
2011: taco uil; Jort Vellinga; Jeroen de Vrij; Sanne K van den Hengel; Martijn J W E Rabelink; Steve J Cramer; Julia J M Eekels; Yavuz Ariyurek; Michiel van Galen; Rob Hoeben
Directed adenovirus evolution using engineered mutator viral polymerases.
Nucleic acids research 2011;39(5):e30.
2011: Jeroen de Vrij; Sanne K van den Hengel; taco uil; Danijela Koppers-Lalic; Iris J C Dautzenberg; Oscar M J A Stassen; Montserrat Bárcena; Masato Yamamoto; Corrina M A de Ridder; Robert Kraaij; Kitty M Kwappenberg; Marco W Schilham; Rob Hoeben
Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors.
Virology 2011;410(1):192-200.
2011: Sanne K van den Hengel; Jeroen de Vrij; taco uil; Martine L Lamfers; Peter Ae Sillevis Smitt; Rob C Hoeben
Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells.
Virology journal 2011;8():162.
2009: taco uil; Jeroen de Vrij; Jort Vellinga; Martijn J W E Rabelink; Steve J Cramer; On Ying A Chan; Margherita Pugnali; Maria Magnusson; Leif Lindholm; Pierre Boulanger; Rob Hoeben
A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers.
The journal of gene medicine 2009;11(11):990-1004.
2008: J de Vrij; taco uil; S K van den Hengel; Steve J Cramer; Danijela Koppers-Lalic; M C Verweij; Emmanuel J H J Wiertz; Jort Vellinga; R A Willemsen; Rob Hoeben
Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
Gene therapy 2008;15(13):978-89.
2007: Maria K Magnusson; Petra Henning; Susanna Myhre; Maria Wikman; taco uil; M Friedman; K M E Andersson; Saw See Hong; Rob Hoeben; N A Habib; S Ståhl; Pierre Boulanger; Leif Lindholm
Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu.
Cancer gene therapy 2007;14(5):468-79.
2007: Jort Vellinga; J de Vrij; Susanna Myhre; taco uil; P Martineau; Leif Lindholm; Rob Hoeben
Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.
Gene therapy 2007;14(8):664-70.
2006: Jort Vellinga; taco uil; Jeroen de Vrij; Martijn J W E Rabelink; Leif Lindholm; Rob Hoeben
A system for efficient generation of adenovirus protein IX-producing helper cell lines.
The journal of gene medicine 2006;8(2):147-54.
2004: Angel A Rivera; Minghui Wang; Kaori Suzuki; taco uil; Victor Krasnykh; David T Curiel; Dirk M Nettelbeck
Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
Virology 2004;320(1):121-34.
2003: taco uil; Hidde J Haisma; Marianne G Rots
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities.
Nucleic acids research 2003;31(21):6064-78.
2003: Anna Kanerva; Kurt R Zinn; Tandra R Chaudhuri; John T Lam; Kaori Suzuki; taco uil; Tanja Hakkarainen; Gerd J Bauerschmitz; Minghui Wang; Bin Liu; Zhihong Cao; Ronald D Alvarez; David T Curiel; Akseli Hemminki
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(3):449-58.
2003: taco uil; Toshiro Seki; Igor Dmitriev; Elena Kashentseva; Joanne T Douglas; Marianne G Rots; Jaap Middeldorp; David T Curiel
Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob.
Cancer gene therapy 2003;10(2):121-4.
2002: Hongju Wu; Toshiro Seki; Igor Dmitriev; taco uil; Elena Kashentseva; Tie Han; David T Curiel
Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency.
Human gene therapy 2002;13(13):1647-53.
2002: Toshiro Seki; Igor Dmitriev; Kaori Suzuki; Elena Kashentseva; Koichi Takayama; Marianne G Rots; taco uil; Hongju Wu; Minghui Wang; David T Curiel
Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo.
Gene therapy 2002;9(16):1101-8.